ADR Alert: Thioridazine Withdrawn Due to Severe Risks

[Manisha]

Thioridazine, a first-generation antipsychotic, has been globally withdrawn due to serious ADRs including:
Sudden cardiac arrest
Extrapyramidal symptoms (EPS)
QT interval prolongation

This case highlights the importance of pharmacovigilance and the need to regularly update prescribing practices based on emerging safety data.

Are we doing enough to monitor and act on ADRs in clinical practice?

[Vishalkumar]

The Thioridazine withdrawal in response to life-threatening ADRs is a forceful reminder:
Pharmacovigilance is not a choice—it’s a necessity.

So, are we doing enough? Not yet—but with ongoing awareness, education, and system enhancements, we can.

[poonam1]

Yes, credits to Pharmacovigilance